Literature DB >> 16829930

Amyloid at the blood vessel wall.

John Hardy, Karen Cullen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16829930     DOI： 10.1038/nm0706-756

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  The interaction of amyloid β and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells.

Authors:  Huan Du; Pengtao Li; Jun Wang; Xuemei Qing; Weihong Li
Journal:  Cell Mol Neurobiol       Date:  2011-08-12       Impact factor: 5.046

Review 2.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

Review 3.  Alzheimer 100--highlights in the history of Alzheimer research.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

4.  AD brain pathology: vascular origins? Results from the HAAS autopsy study.

Authors:  Lenore J Launer; Helen Petrovitch; G Webster Ross; William Markesbery; Lon R White
Journal:  Neurobiol Aging       Date:  2007-04-26       Impact factor: 4.673

5.  Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor.

Authors:  Christian Schachtrup; Paul Lu; Leonard L Jones; Jae K Lee; Jerry Lu; Ben D Sachs; Binhai Zheng; Katerina Akassoglou
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

6.  The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.

Authors:  Donovan McGrowder; Cliff Riley; Errol Y St A Morrison; Lorenzo Gordon
Journal:  Cholesterol       Date:  2010-12-23

Review 7.  Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?

Authors:  Christian Humpel
Journal:  Exp Gerontol       Date:  2010-11-26       Impact factor: 4.032

8.  Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer's disease.

Authors:  Karina O Garcia; Felipe L M Ornellas; Priscila K Matsumoto Martin; Camilla L Patti; Luiz E Mello; Roberto Frussa-Filho; Sang W Han; Beatriz M Longo
Journal:  Front Aging Neurosci       Date:  2014-03-07       Impact factor: 5.750

Review 9.  Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.

Authors:  Marton Siklos; Manel BenAissa; Gregory R J Thatcher
Journal:  Acta Pharm Sin B       Date:  2015-09-26       Impact factor: 11.413

10.  Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheres.

Authors:  Lu Shan; En-Xue Tao; Qing-Hui Meng; Wen-Xia Hou; Kang Liu; Hong-Cai Shang; Jin-Bao Tang; Wei-Fen Zhang
Journal:  Drug Des Devel Ther       Date:  2016-01-25       Impact factor: 4.162
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.